Universe Pharmaceuticals (UPC) Accumulated Expenses: 2022-2024
- Universe Pharmaceuticals' Accumulated Expenses fell 98.18% to $49,475 in Q3 2024 from the same period last year, while for Sep 2024 it was $49,475, marking a year-over-year decrease of 98.18%. This contributed to the annual value of $49,475 for FY2024, which is 98.18% down from last year.
- Per Universe Pharmaceuticals' latest filing, its Accumulated Expenses stood at $49,475 for Q3 2024, which was down 98.18% from $2.7 million recorded in Q3 2023.
- Universe Pharmaceuticals' Accumulated Expenses' 5-year high stood at $2.7 million during Q3 2023, with a 5-year trough of $49,475 in Q3 2024.
- For the 3-year period, Universe Pharmaceuticals' Accumulated Expenses averaged around $1.8 million, with its median value being $2.5 million (2022).
- Per our database at Business Quant, Universe Pharmaceuticals' Accumulated Expenses rose by 6.79% in 2023 and then crashed by 98.18% in 2024.
- Universe Pharmaceuticals' Accumulated Expenses (Quarterly) stood at $2.5 million in 2022, then climbed by 6.79% to $2.7 million in 2023, then tumbled by 98.18% to $49,475 in 2024.
- Its last three reported values are $49,475 in Q3 2024, $2.7 million for Q3 2023, and $2.5 million during Q3 2022.
